These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6383325)

  • 1. Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents.
    Volm M
    Behring Inst Mitt; 1984 May; (74):273-84. PubMed ID: 6383325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
    Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
    Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitivity testing of Wilms' tumors to cytostatic agents with an autoradiographic in vitro short-term test.
    Willnow U
    Neoplasma; 1984; 31(6):719-26. PubMed ID: 6097829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
    Eidtmann H; Jonat W; Maass H
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):477-81. PubMed ID: 4029587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro resistance testing of tumors in relation to cytostatics. 2. Examinations with human malignomas].
    Possinger K; Hartenstein R; Ehrhart H
    Onkologie; 1980 Dec; 3(6):297-300. PubMed ID: 7012727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of DNA ploidy to chemoresistance of tumors as measured by in vitro tests.
    Volm M; Efferth T
    Cytometry; 1990; 11(3):406-10. PubMed ID: 1971209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uptake of radioactive precursors for the evaluation of sensitivity of anticancer drugs against cancer cells].
    Ichihashi H; Kondo T
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1130-8. PubMed ID: 6471419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Testing of sensitivity of human tumours to cytostatics in a rapid in vitro test (author's transl)].
    Volm M
    Dtsch Med Wochenschr; 1980 Oct; 105(43):1493-6. PubMed ID: 7428654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro short-term test to determine the resistance of human tumors to chemotherapy: Group for Sensitivity Testing of Tumors (KSST).
    Cancer; 1981 Nov; 48(10):2127-35. PubMed ID: 7197581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Testing of solid tumors in childhood for sensitivity against cytostatic agents using an autoradiographic in vitro method (short-term method) (author's transl)].
    Willnow U
    Arch Geschwulstforsch; 1979; 49(3):201-10. PubMed ID: 227341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance testing and chemotherapy results of bronchial tumours (author's transl)].
    Volm M; Wayss K; Mattern J; Kleckow M; Vogt-Moykopf I
    Dtsch Med Wochenschr; 1978 Aug; 103(32):1266-70. PubMed ID: 668581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of broad spectrum resistance of tumors towards anticancer drugs.
    Efferth T; Konkimalla VB; Wang YF; Sauerbrey A; Meinhardt S; Zintl F; Mattern J; Volm M
    Clin Cancer Res; 2008 Apr; 14(8):2405-12. PubMed ID: 18413831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of testing tumor resistance (in vitro--in vivo) in breast cancer].
    Bartzke G; Rössler H; Seufert R; Möbus V; Kreienberg R
    Geburtshilfe Frauenheilkd; 1987 Oct; 47(10):690-4. PubMed ID: 3678785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
    O'Meara AT; Sevin BU
    Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitivity of primary hepatic neoplasms: a potential new approach to the treatment of hepatoma.
    Van Thiel DH; Brems J; Holt D; Hamdani R; Yong S
    Hepatogastroenterology; 2002; 49(45):730-4. PubMed ID: 12063980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance in chemotherapy for breast cancer.
    Saeki T; Tsuruo T; Sato W; Nishikawsa K
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of the histoculture drug response assay.
    Furukawa T; Kubota T; Hoffman RM
    Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.